Purchase Order 75N95024P00314
Award Date 7/1/24
Potential Completion Date 6/30/27
Potential Value $56K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Beverly, MA 01915, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This sole source contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Chemaxon LLC is for annual license renewals of JChem Oracle Cartridge and Marvin JS software. Valued at $10,490, the firm fixed price contract provides 100 user licenses for both the JChem Oracle Cartridge and Marvin JS Library from July 1, 2023 through June 30, 2024 with an additional four 12-month option periods. The software licenses are...
- <p>The National Institute on Drug Abuse issued a purchase order to Andor Technology, Inc. on July 11, 2024 for Imaris software license renewal at a firm fixed price of $19,798.00. The order has an ultimate completion date of July 10, 2025. Place of performance is Concord, Massachusetts. The procurement was conducted under simplified acquisition procedures without set-aside designation.</p>
- This is a $109,853.26 firm fixed price purchase order awarded by the National Institute on Drug Abuse, a component of the U.S. Department of Health and Human Services, to Clarivate Analytics (Us) LLC. The contract provides a user license and subscription to the OFF-X (Translational Safety/Toxicology) and Cortellis Drug Discovery Intelligence software with the Biomarkers Module for the period of April 1, 2024 through March 31, 2025, with a total contract period of performance through March 31,...
- The National Institute on Drug Abuse awarded a purchase order to Eckert & Ziegler Radiopharma, Inc. for $76,350.00 on September 14, 2021. This firm fixed-price purchase order is for the administrative de-obligation of unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability of these funds. The ultimate completion date is November 30, 2021. Work is performed in Wilmington,...
- The National Institute on Drug Abuse Confocal and Electron Microscopy Core and Histology and Imaging Core requires continued maintenance of the Imaris software under a $10,632.89 firm fixed price purchase order awarded to Andor Technology, Inc. The contract will provide software support services from March 3, 2024 through March 2, 2025 to manage three-dimensional reconstruction datasets. Funding is provided by the Department of Health and Human Services National Institutes of Health National...
- The National Institute on Drug Abuse awarded a $198,641.93 firm fixed-price purchase order to The Mathworks, Inc. for institute-wide licenses of MATLAB and Simulink software covering the period from September 1, 2024, through August 31, 2026, with an ultimate completion date of August 31, 2027. This non-competitive, sole-source procurement was justified under Federal Acquisition Regulation 6.302-1, as MATLAB is the only software capable of executing MATLAB-written code. The software will support...
- Chemaxon LLC has been awarded a $23,865 firm fixed price purchase order by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to provide Chemaxon software licenses for use across the NIH's Protein Structure Prediction Pipeline and Enhanced Therapeutics Structure Prediction programs through September 2024. The licenses will support the NIH's efforts to advance understanding of neurological disorders and develop new treatments. As the prime contractor,...
- <p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $12,000.00 firm-fixed-price purchase order contract to Vivpro Corp, a self-certified small disadvantaged business, for subscription licenses. The contract has an ultimate completion date of June 24, 2025 and was awarded on June 13, 2024. This contract does not have a set-aside designation.</p>
- The National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, awarded a $83,907.10 firm-fixed-price purchase order to Biotage, LLC for the supply of a Biotage V-10 Touch System (Evaporator). This equipment will support NIDA's Automated Synthesis Platform for Innovative Research and Execution (ASPIRE) initiative, enabling rapid drying of organic and aqueous samples generated through chemistry workflows. The purchase order was awarded on...
- <p>The National Institute on Drug Abuse awarded a purchase order to Life Technologies Corporation for $16,990.88 on July 30, 2019. The order carries no set-aside designation and has a firm fixed price structure. Performance takes place in Carlsbad, California. The ultimate completion date is July 31, 2022. The order is part of the FY26 UDO Initiative.</p>